Skip to content

The impact of individualized lung-protective ventilation strategies on postoperative pulmonary complications in patients with high-risk lung cancer after resection: A prospective randomized controlled trial

The impact of individualized lung-protective ventilation strategies on postoperative pulmonary complications in patients with high-risk lung cancer after resection: A prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109678
Enrollment
Unknown
Registered
2025-09-23
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

experimental group:Individualized PEEP titration is adopted for PEEP during mechanical ventilation
control group:When performing mechanical ventilation, a fixed PEEP of 5 is adopted

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Lung cancer patients scheduled for elective general anesthesia thoracoscopic or open surgical lung resection; 2. ARISCAT score >=45 ; 3. During the operation, lung isolation is required and single-lung ventilation should be implemented; 4. The patient should be hospitalized for at least 2 days after the operation; 5. American Society of Anesthesiologists (ASA) Health Classification II -III.

Exclusion criteria

Exclusion criteria: 1. Obesity, BMI> 35; 2. There were moderate symptoms of dyspnea before the operation, PaO2/FiO2<200mmHg ; 3. Preoperative heart failure: NYHA grade greater than or equal to grade IV; 4. Preoperative hemodynamic instability, CI < 2.5 L/min/m2 and/or positive inotropic drugs are required for support; 5. There has been mechanical ventilation in the past 15 days; 6. Those who had pneumothorax before the operation or showed pulmonary bullae on imaging examinations; 7. Those who have bronchiectasis, respiratory tract infection, persistent cough with expectoration and excessive secretions in the lungs before the operation; 8. CPAP breathing assistance is required before the operation; 9. Participate in other clinical trials; 10. Those who are expected to be intolerant to PEEP titration (those expected to experience hypotension or hypoxia during the titration process); 11. Any conditions that are not suitable for EIT measurement (pacemakers, automated implantable defibrillators, implant pumps).

Design outcomes

Primary

MeasureTime frame
The incidence of pulmonary complications during postoperative hospitalization;

Secondary

MeasureTime frame
Postoperative hospital stay;Other complications during hospitalization;driving pressure;lung compliance;Arterial blood oxygenation index;mean arterial pressure;Complications from discharge to 30 days after the operation;Incidence of hypoxemia;extubation time;

Countries

China

Contacts

Public ContactJingxiang Wu

Shanghai Chest Hospital

wu_jingxiang@sjtu.edu.cn+86 189 3085 7186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026